Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22F2N4O |
Molecular Weight | 348.3903 |
Optical Activity | ( - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N1CCC(=C)CC1)[C@](O)(CN2C=NC=N2)C3=CC=C(F)C=C3F
InChI
InChIKey=NFEZZTICAUWDHU-RDTXWAMCSA-N
InChI=1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1
Molecular Formula | C18H22F2N4O |
Molecular Weight | 348.3903 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:03:57 UTC 2023
by
admin
on
Sat Dec 16 17:03:57 UTC 2023
|
Record UNII |
J82SB7FXWB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175487
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
||
|
WHO-ATC |
D01AC19
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
J82SB7FXWB
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
J82SB7FXWB
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
DTXSID40167787
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
489181
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
YY-95
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
Efinaconazole
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
100000163626
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
DB09040
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
CLENAFIN
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | APPROVED JULY 2014 | ||
|
9349
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL2103877
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
C97998
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
SUB177957
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
m11729
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
8341
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
4874
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
82718
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
Efinaconazole
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | |||
|
1539753
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
164650-44-6
Created by
admin on Sat Dec 16 17:03:58 UTC 2023 , Edited by admin on Sat Dec 16 17:03:58 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
In-vivo, H3 was the major metabolite in human plasma and it is inactive. This was the only metabolite that was higher or equal to efinaconazole levels
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
MAJOR
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
DAILY APPLICATIONS |
|
||